FRS2 and prostate carcinoma: Although FIIN1/FIIN2 inhibited downstream FGFR signaling (p-FRS2α and p-ERK1/2) across the cell lines, 10 μM treatment was cytotoxic to both prostate cancer cells and CAFs.